MX2020002008A - Tratamientos antivirales intravenosos. - Google Patents

Tratamientos antivirales intravenosos.

Info

Publication number
MX2020002008A
MX2020002008A MX2020002008A MX2020002008A MX2020002008A MX 2020002008 A MX2020002008 A MX 2020002008A MX 2020002008 A MX2020002008 A MX 2020002008A MX 2020002008 A MX2020002008 A MX 2020002008A MX 2020002008 A MX2020002008 A MX 2020002008A
Authority
MX
Mexico
Prior art keywords
antiviral treatments
intravenous
intravenous antiviral
treatments
kits
Prior art date
Application number
MX2020002008A
Other languages
English (en)
Inventor
Pooran Chand
Shanta Bantia
Yarlagadda Sudhakara Babu
Arnold Shane
John Michael Kilpatrick
Original Assignee
Biocryst Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38169715&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2020002008(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2006/013535 external-priority patent/WO2007117241A1/en
Application filed by Biocryst Pharm Inc filed Critical Biocryst Pharm Inc
Publication of MX2020002008A publication Critical patent/MX2020002008A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención proporciona formas de dosificación unitarias, kits y métodos útiles para tratar infecciones virales.
MX2020002008A 2006-02-13 2007-02-12 Tratamientos antivirales intravenosos. MX2020002008A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77274806P 2006-02-13 2006-02-13
PCT/US2006/013535 WO2007117241A1 (en) 2006-04-12 2006-04-12 Intramuscular antiviral treatments
PCT/US2007/003755 WO2007095218A1 (en) 2006-02-13 2007-02-12 Intravenous antiviral treatments

Publications (1)

Publication Number Publication Date
MX2020002008A true MX2020002008A (es) 2020-07-13

Family

ID=38169715

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2008010394A MX2008010394A (es) 2006-02-13 2007-02-12 Tratamientos antivirales intravenosos.
MX2020002008A MX2020002008A (es) 2006-02-13 2007-02-12 Tratamientos antivirales intravenosos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2008010394A MX2008010394A (es) 2006-02-13 2007-02-12 Tratamientos antivirales intravenosos.

Country Status (11)

Country Link
EP (1) EP1986626A1 (es)
JP (3) JP2009538822A (es)
KR (9) KR102475176B1 (es)
AU (2) AU2007215156A1 (es)
BR (1) BRPI0707769A2 (es)
CA (1) CA2642260C (es)
EA (1) EA025483B1 (es)
HK (1) HK1212250A1 (es)
MX (2) MX2008010394A (es)
MY (1) MY166063A (es)
WO (1) WO2007095218A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008010394A (es) * 2006-02-13 2009-01-12 Biocryst Pharm Inc Tratamientos antivirales intravenosos.
CN101367750B (zh) * 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途
KR20220033561A (ko) 2020-09-07 2022-03-17 주식회사 경보제약 페라미비르 화합물을 포함하는 프리믹스 제형의 제약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9711095A (pt) * 1996-06-14 2001-07-17 Biocryst Pharm Inc Composto de ciclopentano substituìdo, composição e método para inibir neuraminidase de vìrus influenza e método para tratar infecção de vìrus influenza
AR016162A1 (es) * 1997-12-17 2001-06-20 Biocryst Pharm Inc Compuestos ciclopentano y ciclopenteno sustituidos que son de utilidad como inhibidores de la neuraminidasa y composicion que los contiene.
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
MX2008010394A (es) * 2006-02-13 2009-01-12 Biocryst Pharm Inc Tratamientos antivirales intravenosos.

Also Published As

Publication number Publication date
KR101992585B1 (ko) 2019-06-25
MX2008010394A (es) 2009-01-12
WO2007095218A1 (en) 2007-08-23
HK1212250A1 (en) 2016-06-10
CA2642260A1 (en) 2007-08-23
KR102475176B1 (ko) 2022-12-07
KR20160129105A (ko) 2016-11-08
KR20080096829A (ko) 2008-11-03
KR101992585B9 (ko) 2022-09-20
EP1986626A1 (en) 2008-11-05
JP2015180695A (ja) 2015-10-15
MY166063A (en) 2018-05-23
KR20210076189A (ko) 2021-06-23
JP2009538822A (ja) 2009-11-12
AU2007215156A1 (en) 2007-08-23
KR20140132778A (ko) 2014-11-18
KR20210135632A (ko) 2021-11-15
KR20180024027A (ko) 2018-03-07
CA2642260C (en) 2016-08-09
KR102323339B1 (ko) 2021-11-08
JP6073202B2 (ja) 2017-02-01
EA200870263A1 (ru) 2009-06-30
KR20230003248A (ko) 2023-01-05
JP2013256527A (ja) 2013-12-26
EA025483B1 (ru) 2016-12-30
KR20200143519A (ko) 2020-12-23
KR20190072681A (ko) 2019-06-25
AU2013216632A1 (en) 2013-08-29
AU2013216632B2 (en) 2016-09-01
KR102267754B1 (ko) 2021-06-23
KR102194015B1 (ko) 2020-12-22
BRPI0707769A2 (pt) 2011-05-10

Similar Documents

Publication Publication Date Title
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
MX2010002318A (es) Derivados azaindol 2,3-sustituidos para tratar infecciones virales.
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
MX2009009761A (es) Composiciones y estuches para tratamiento de la influenza.
WO2008127364A3 (en) Antiviral compounds and use thereof
MX2009008617A (es) Uso de antagonistas de interleucina-23 para el tratamiento de infeccion.
MX360301B (es) Moleculas pequeñas que contienen boro como agentes antiinflamatorios.
UA118645C2 (uk) Спосіб комбінованої терапії раку наночастинками, що містять рапаміцин і альбумін
WO2009149179A3 (en) Enhanced antiviral therapy methods and devices
MX354099B (es) Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama.
TW200738270A (en) Method of treating depression using a TNFα antibody
MX363189B (es) Productos químicos, composiciones y métodos para tratamiento y prevención de infecciones de virus orthopox y enfermedades asociadas.
WO2008115281A3 (en) Compounds for treating viral infections
MX2010003916A (es) Espiro-pirrolidinas y su uso contra infeccion por el virus de hepatitis c (hcv) y por el virus de inmunodeficiencia humana (vih).
TNSN08400A1 (en) Organic compounds and their uses
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
MX2009005300A (es) Combinacion de un inhibidor de acido desoxirribonucleico polimerasa-alfa y un inhibidor de una cinasa de punto de verificacion para trastornos proliferativos.
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
MX2008015775A (es) Compuestos y composiciones para tratamiento de cancer.
MXPA04006572A (es) Terapia de combinacion antivirica.
TN2011000204A1 (en) Cycloundecadepsipeptide compounds and use of said compounds as a medicament
MX2007008158A (es) Tratamiento de trastornos por el virus de hepatitis c.
TNSN08496A1 (en) Aminothiazoles and their uses
MX2009012767A (es) Metodos de tratamiento de infecciones fungicas.
MX2009009693A (es) Metodos para activar irs-1 y akt.